找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag; Proceedings of the N Joel Morganroth,

[復(fù)制鏈接]
查看: 8350|回復(fù): 51
樓主
發(fā)表于 2025-3-21 19:01:31 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag
副標(biāo)題Proceedings of the N
編輯Joel Morganroth,E. Neil Moore
視頻videohttp://file.papertrans.cn/831/830795/830795.mp4
叢書名稱Developments in Cardiovascular Medicine
圖書封面Titlebook: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag; Proceedings of the N Joel Morganroth,
描述The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents. The use of thrombolytic agents has become one of the major advances in clinical intensive cardiologic care in the 1980s. While the lysis of clot(s) obstructing a major coronary artery should reverse or prevent the damage of acute myocardial ischemia and infarction, one must carefully consider the potential risks of such agents in regards to their potential benefits. The time when a thrombolytic agent should be administered to maximize benefit as well as how one defines a dose response relationship using intravenous critical care medicines were discussed as important clinical trial issues. The benefit versus risk data on currently available thrombolytic agents was reviewed and the potential roles for adjunctive agents addressed. Overall s
出版日期Conference proceedings 1989
關(guān)鍵詞artery; cardiovascular; drugs; myocardial infarction; sudden cardiac death
版次1
doihttps://doi.org/10.1007/978-1-4613-1605-3
isbn_softcover978-1-4612-8888-6
isbn_ebook978-1-4613-1605-3Series ISSN 0166-9842
issn_series 0166-9842
copyrightKluwer Academic Publishers 1989
The information of publication is updating

書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag影響因子(影響力)




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag影響因子(影響力)學(xué)科排名




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag網(wǎng)絡(luò)公開度




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag被引頻次




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag被引頻次學(xué)科排名




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag年度引用




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag年度引用學(xué)科排名




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag讀者反饋




書目名稱Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Ag讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:21:11 | 只看該作者
Such integrations frequently involve (not always in immediately re- cognizable form) elliptic functions and elliptic integrals. The numerous books written on elliptic integrals, while of great value to the student or mathematician, are not especially suitable for the scientist whose primary objectiv
板凳
發(fā)表于 2025-3-22 02:08:04 | 只看該作者
地板
發(fā)表于 2025-3-22 04:50:57 | 只看該作者
5#
發(fā)表于 2025-3-22 12:44:13 | 只看該作者
Allan M. Ross M.D.eat deal of research, most of which has occurred in the past several decades, has revealed that embodied influences are seemingly ubiquitous and findings of this type have led to the suggestion that embodiment is foundational to the manner in which individuals think, feel, and act. In the present in
6#
發(fā)表于 2025-3-22 14:45:12 | 只看該作者
7#
發(fā)表于 2025-3-22 18:14:41 | 只看該作者
8#
發(fā)表于 2025-3-22 22:20:18 | 只看該作者
9#
發(fā)表于 2025-3-23 04:43:00 | 只看該作者
10#
發(fā)表于 2025-3-23 07:10:53 | 只看該作者
E. Neil Moore D.V.M., Ph.D.,Joseph F. Spear Ph.D.or diagnosing open globe. If the history or physical examination suggests open globe but imaging is negative, the patient may still need surgical exploration due to the poor sensitivity of the test. In cases of suspected IOFB, CT scanning of orbits is the preferred and most sensitive modality. MRI s
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 21:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
高尔夫| 察隅县| 禄丰县| 铁岭县| 南召县| 青冈县| 凤城市| 德令哈市| 常州市| 锡林浩特市| 阿合奇县| 寿光市| 乌审旗| 宁都县| 澜沧| 鹿邑县| 邯郸市| 衡阳县| 华阴市| 鱼台县| 白河县| 老河口市| 福州市| 友谊县| 汉源县| 浦东新区| 吉安市| 宣威市| 布尔津县| 平阴县| 昆明市| 察哈| 浮梁县| 长乐市| 修水县| 新兴县| 留坝县| 北辰区| 盘山县| 辛集市| 鄂尔多斯市|